Heart Disease
New findings in heart disease described from the Serbia and Montenegro, Norway and Australia
Published in Medical Letter on the CDC and FDA, June 7th, 2006
Study 1: The Olympus immuno-turbidimetric high-sensitivity C-reactive protein assay is effective for cardiovascular risk estimation.
According to recent research from Serbia and Montenegro, "Increased C-reactive protein (CRP) concentration within the reference interval (<10.0 mg/L) is a strong predictor of cardiovascular disease (CVD) in apparently healthy adults. Cutoff points for use of CRP in estimating CVD risk are <1, 1-3, and >3 mg/L for low, average and high relative risk, respectively. For measuring CRP concentrations to assess...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Diabetes Epidemiology
Diabetes processes of care and intermediate outcomes have improved in U.S. - Environmental Health
Perfluorochemicals have been found in serum samples from U.S. residents - HIV/AIDS Therapy
Baseline protease genotype affects HIV response to atazanavir/ritonavir - Norovirus Diagnosis
TaqMan RT-PCR allows rapid norovirus detection, typing, and quantification - Sexual & Reproductive Health
Viagra use is linked to unprotected insertive anal sex in men who have sex with men - Adverse Drug Reaction
Bausch & Lomb responds to U.S. CDC release of data on Fusarium keratitis cases - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
